bioRxiv ScienceSearch

Biology subjects

Mitchell, H. D.

Publications and source records attributed to Mitchell, H. D..

3 recordsLinked to original sources

Proteomics of natural bacterial isolates powered by deep learning-based de novo identification.

Metaproteomics has been increasingly utilized for high-throughput molecular characterization in complex environments and has been demonstrated to provide insights into microbial composition and functional roles in soil systems. Despite its potential for the study of microbiomes, significant challenges remain in data analysis, including the creation of a sample-specific protein sequence database as the taxonomic composition of soil is often unknown. Almost all metaproteome analysis tools require this database and their accuracy and sensitivity suffer when the database is incomplete or contains extraneous sequences from organisms which are not present. Here, we leverage a de novo peptide sequencing approach to identify sample composition directly from metaproteomic data. First, we created a deep learning model, Kaiko, to predict the peptide sequences from mass spectrometry data, and trained it on 5 million peptide-spectrum matches from 55 phylogenetically diverse bacteria. After training, Kaiko successfully identified unsequenced soil isolates directly from proteomics data. Finally, we created a pipeline for metaproteome database generation using Kaiko. We tested the pipeline on native soils collected in Kansas, showing that the de novo sequencing model can be employed to construct the sample-specific protein database instead of relying on (un)matched metagenomes. Our pipeline identified all highly abundant taxa from 16S ribosomal RNA sequencing of the soil samples and also uncovered several additional species which were strongly represented only in proteomic data. Our pipeline offers an alternative and complementary method for metaproteomic data analysis by creating a protein database directly from proteomic data, thus removing the need for metagenomic sequencing. Significance StatementProteomic characterization of environmental samples, or metaproteomics, reveals microbial activity critical to our understanding of climate, nutrient cycling and human health. Metaproteomic samples originate from diverse environs, such as soil and oceans. One option for data analysis is a de novo interpretation of the mass spectra. Unfortunately, the current generation of de novo algorithms were primarily trained on data originating from human proteins. Therefore, these algorithms struggle with data from environmental samples, limiting our ability to analyze metaproteomics data. To address this challenge, we trained a new algorithm with data from dozens of diverse environmental bacteria and achieved significant improvements in accuracy across a broad range of organisms. This generality opens proteomics to the world of natural isolates and microbiomes.

bioinformatics

Combination attenuation offers strategy for live-attenuated coronavirus vaccines

With an ongoing threat posed by circulating zoonotic strains, new strategies are required to prepare for the next emergent coronavirus (CoV). Previously, groups had targeted conserved coronavirus proteins as a strategy to generate live-attenuated vaccine strains against current and future CoVs. With this in mind, we explored whether manipulation of CoV NSP16, a conserved 2O methyltransferase (MTase), could provide a broad attenuation platform against future emergent strains. Using the SARS-CoV mouse model, a NSP16 mutant vaccine was evaluated for protection from heterologous challenge, efficacy in the aging host, and potential for reversion to pathogenesis. Despite some success, concerns for virulence in the aged and potential for reversion makes targeting NSP16 alone an untenable approach. However, combining a 2O MTase mutation with a previously described CoV fidelity mutant produced a vaccine strain capable of protection from heterologous virus challenge, efficacy in aged mice, and no evidence for reversion. Together, the results indicate that targeting the CoV 2O MTase in parallel with other conserved attenuating mutations may provide a platform strategy for rapidly generating live-attenuated coronavirus vaccines.\n\nSignificanceEmergent coronaviruses remain a significant threat to global public health and rapid response vaccine platforms are needed to stem future outbreaks. However, failure of many previous CoV vaccine formulations has clearly highlighted the need to test efficacy under different conditions and especially in vulnerable populations like the aged and immune-compromised. This study illustrates that despite success in young models, the NSP16 mutant carries too much risk for pathogenesis and reversion in vulnerable models to be used as a stand-alone vaccine strategy. Importantly, the NSP16 mutation can be paired with other attenuating approaches to provide robust protection from heterologous challenge and in vulnerable populations. Coupled with increased safety and reduced pathogenesis, the study highlights the potential for NSP16 attenuation as a major component of future live-attenuated coronavirus vaccines.

microbiology

MERS-CoV NSP16 necessary for IFN resistance and viral pathogenesis

Coronaviruses encode a mix of highly conserved and novel genes as well as genetic elements necessary for infection and pathogenesis, raising the possibility for common targets for attenuation and therapeutic design. In this study, we focus on the highly conserved nonstructural protein (NSP) 16, a viral 2O methyl-transferase (MTase) that encodes critical functions in immune modulation and infection. Using reverse genetics, we disrupted a key motif in the conserved KDKE motif of MERS NSP16 (D130A) and evaluated the effect on viral infection and pathogenesis. While the absence of 2O MTase activity had only marginal impact on propagation and replication in Vero cells, the MERS dNSP16 mutant demonstrated significant attenuation relative to control both in primary human airway cultures and in vivo. Further examination indicated the MERS dNSP16 mutant had a type I IFN based attenuation and was partially restored in the absence of IFIT molecules. Importantly, the robust attenuation permitted use of MERS dNSP16 as a live attenuated vaccine platform protecting from challenge with a mouse adapted MERS-CoV strain. These studies demonstrate the importance of the conserved 2O MTase activity for CoV pathogenesis and highlight NSP16 as a conserved universal target for rapid live attenuated vaccine design in an expanding CoV outbreak setting.\n\nSignificanceCoronavirus emergence in both human and livestock represents a significant threat to global public health, as evidenced by the sudden emergence of SARS-CoV, MERS-CoV, PEDV and swine delta coronavirus in the 21st century. These studies describe an approach that effectively targets the highly conserved 2O methyl-transferase activity of coronaviruses for attenuation. With clear understanding of the IFN/IFIT based mechanism, NSP16 mutants provide a suitable target for a live attenuated vaccine platform as well as therapeutic development for both current and future emergent CoV strains. Importantly, other approaches targeting other conserved pan-coronavirus functions have not yet proven effective against MERS-CoV, illustrating the broad applicability of targeting viral 2O MTase function across coronaviruses.

microbiology